Samsung Biologics Co.,Ltd.
207940
Clasificación en acciones
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Precio por acción
$1,028.49
Capitalización bursátil
$47.88B
Cambio (1 día)
-3.67%
Cambio (1 año)
-18.37%
País
KR
Comercio Samsung Biologics Co.,Ltd. (207940)
Categoría
Healthcare
Historial del precio de la acción de Samsung Biologics Co.,Ltd. (207940)
Precio más alto de cierre: $917.33 el 2026-10-01
Precio más bajo de cierre: $215.60 el 2016-11-01
Precio más bajo de cierre: $215.60 el 2016-11-01
Historial del precio de la acción de Samsung Biologics Co.,Ltd. desde 2016 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | -6.12% |
| 2025 | 12.74% |
| 2024 | 21.95% |
| 2023 | -14.64% |
| 2022 | -16.07% |
| 2021 | 2.83% |
| 2020 | 117.47% |
| 2019 | 6.18% |
| 2018 | -1.56% |
| 2017 | 164.22% |
| 2016 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
